BR0009663A - Composições de vacinas antibacterianas - Google Patents

Composições de vacinas antibacterianas

Info

Publication number
BR0009663A
BR0009663A BR0009663-6A BR0009663A BR0009663A BR 0009663 A BR0009663 A BR 0009663A BR 0009663 A BR0009663 A BR 0009663A BR 0009663 A BR0009663 A BR 0009663A
Authority
BR
Brazil
Prior art keywords
vaccine compositions
antibacterial
antibacterial vaccine
vaccines
gram
Prior art date
Application number
BR0009663-6A
Other languages
English (en)
Portuguese (pt)
Inventor
David E Lowery
Troy E Fuller
Michael J Kennedy
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of BR0009663A publication Critical patent/BR0009663A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BR0009663-6A 1999-04-09 2000-04-06 Composições de vacinas antibacterianas BR0009663A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12868999P 1999-04-09 1999-04-09
US15345399P 1999-09-10 1999-09-10
PCT/US2000/009218 WO2000061724A2 (en) 1999-04-09 2000-04-06 Anti-bacterial vaccine compositions

Publications (1)

Publication Number Publication Date
BR0009663A true BR0009663A (pt) 2002-04-09

Family

ID=26826843

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0009663-6A BR0009663A (pt) 1999-04-09 2000-04-06 Composições de vacinas antibacterianas

Country Status (14)

Country Link
US (5) US20070237793A1 (https=)
EP (5) EP2281835B1 (https=)
JP (4) JP4892134B2 (https=)
KR (4) KR20060116041A (https=)
CN (1) CN1351653A (https=)
AR (1) AR029622A1 (https=)
AU (2) AU780887B2 (https=)
BR (1) BR0009663A (https=)
CA (1) CA2366520C (https=)
ES (2) ES2439645T3 (https=)
HK (1) HK1045856A1 (https=)
MX (1) MXPA01010207A (https=)
NZ (2) NZ530012A (https=)
WO (1) WO2000061724A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790950B2 (en) * 1999-04-09 2004-09-14 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
CA2366520C (en) * 1999-04-09 2013-10-01 Zoetis Services Llc Anti-bacterial vaccine compositions
WO2003029470A1 (en) * 2001-09-26 2003-04-10 Kyowa Hakko Kogyo Co., Ltd. PROCESS FOR PRODUCING α1,4-GALACTOSYLTRANSFERASE AND GALACTOSE-CONTAINING COMPLEX SUGAR
US7449178B2 (en) 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
DK1350796T3 (da) * 2002-04-05 2009-03-02 Merial Sas Attenuerede gramnegative bakterier
GB0228691D0 (en) * 2002-12-09 2003-01-15 Imp College Innovations Ltd Bacterial virulence genes
EP1602720B1 (en) * 2003-03-05 2010-11-03 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Process for producing heterologous protein in e. coli
US8937154B2 (en) 2006-10-05 2015-01-20 New York Blood Center, Inc. Stabilized therapeutic small helical antiviral peptides
AU2007307254A1 (en) * 2006-10-05 2008-04-17 New York Blood Center, Inc. Stabilized therapeutic small helical antiviral peptides
CA2725227A1 (en) 2008-05-06 2009-11-12 Asim Kumar Debnath Antiviral cell penetrating peptides
DE102011016772B8 (de) * 2011-04-12 2024-08-14 Mercedes-Benz Group AG Verfahren und Vorrichtung zur Überwachung zumindest eines Fahrzeuginsassen und Verfahren zum Betrieb zumindest einer Assistenzvorrichtung
ES2824402T3 (es) 2013-11-01 2021-05-12 Boehringer Ingelheim Animal Health Usa Inc Vacunas atenuadas contra Pasteurella multocida y procedimientos de fabricación y uso de las mismas
JP7183168B2 (ja) * 2017-02-10 2022-12-05 エピトピックス， エルエルシー タンパク質、及びＰａｓｔｅｕｒｅｌｌａタンパク質を含有する免疫化組成物、ならびに使用方法
WO2022072431A1 (en) 2020-09-30 2022-04-07 Zoetis Services Llc Novel pasteurella multocida strains and vaccines having hyac and nanp deletions
TW202219269A (zh) * 2020-09-30 2022-05-16 美國農業部 新型多殺性巴斯德氏菌株及具有ｈｙａＣ與ｎａｎＰ缺失之疫苗
CN113567415A (zh) * 2021-07-05 2021-10-29 广西大学 表面增强拉曼散射结合免疫层析技术检测布鲁氏杆菌方法
CN115925536B (zh) * 2022-08-01 2025-02-28 北京农学院 靶向抑制DksA的小分子抑制剂和应用
CN116593695B (zh) * 2022-12-29 2025-08-05 重庆澳龙生物制品有限公司 一种牛多杀性巴氏杆菌荚膜a型elisa抗体检测试剂盒及其制备方法和应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL52815A (en) * 1977-08-24 1983-03-31 Israel State Fowl cholera vaccine and process for producing an attenuated non-virulent strain of pasteurella multocida
US4735801A (en) * 1982-09-07 1988-04-05 Board Of Trustees Of Leland Stanford Jr. University Novel non-reverting salmonella live vaccines
US5077044A (en) * 1980-05-19 1991-12-31 The Board Of Trustees Of The Leland Stanford Jr. University Novel non-reverting shigella live vaccines
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
DE3426532A1 (de) 1984-07-18 1986-01-30 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig Verwendung einer dna-sequenz zur expression sowie dna-struktur und expressionsvektor mit der dna-sequenz
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US4877612A (en) 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
ES2039229T3 (es) 1986-01-14 1993-09-16 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Procedimiento para la preparacion de complejos inmunogenicos y composiciones farmaceuticas que contienen estos complejos.
US4806352A (en) 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
CA1340522C (en) 1987-03-10 1999-05-04 Heinz Dobeli Fusion proteins containing neighbouring histidines for improved purification
IL86583A0 (en) * 1987-06-04 1988-11-15 Molecular Eng Ass Vaccine containing a derivative of a microbe and method for the production thereof
US5376369A (en) * 1987-11-03 1994-12-27 Syntex (U.S.A.) Inc. Vaccine adjuvant
DK46693D0 (https=) * 1993-04-23 1993-04-23 Novo Nordisk As
DK0574466T3 (da) * 1991-03-05 1999-11-08 Wellcome Found Udtrykkelse af rekombinante proteiner i svækkede bakterier
US5840312A (en) * 1991-05-02 1998-11-24 Institut Pasteur Recombinant Bacillus anthracis strains unable to produce the lethal factor protein or edema factor protein
EP0668779A4 (en) * 1992-11-06 1996-08-21 Univ Minnesota Vaccine to protect against pasteurellosis - infection by P.multocida.
US5585277A (en) 1993-06-21 1996-12-17 Scriptgen Pharmaceuticals, Inc. Screening method for identifying ligands for target proteins
US5587305A (en) 1993-12-06 1996-12-24 The United States Of America As Represented By The Department Of Agriculture Pasteurella haemolytica transformants
AU1662595A (en) 1994-01-28 1995-08-15 Herbert Altmann Method of determining the activity of a regulatory factor, and use of the method
JP3709564B2 (ja) 1994-08-30 2005-10-26 味の素株式会社 Ｌ−バリン及びｌ−ロイシンの製造法
KR20060099543A (ko) 1994-12-09 2006-09-19 임페리얼 컬리지 이노베이션스 리미티드 유전자의 동정
CA2170839A1 (en) * 1995-03-01 1996-09-02 Janet Macinnes Bacterial preparations, method for producing same, and their use as vaccines
US6355450B1 (en) 1995-04-21 2002-03-12 Human Genome Sciences, Inc. Computer readable genomic sequence of Haemophilus influenzae Rd, fragments thereof, and uses thereof
GB9518220D0 (en) 1995-09-06 1995-11-08 Medical Res Council Checkpoint gene
US5994066A (en) 1995-09-11 1999-11-30 Infectio Diagnostic, Inc. Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US5925354A (en) 1995-11-30 1999-07-20 Michigan State University Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae
US5840556A (en) * 1996-05-08 1998-11-24 The United States Of America As Represented By The Department Of Agriculture Molecular genetic construction of vaccine strains of pasteurellaceae
CA2206575A1 (en) * 1996-05-31 1997-11-30 Akzo Nobel Nv Live attenuated rtx-producing bacteria of the family pasteurellaceae
US6020474A (en) 1997-01-15 2000-02-01 Incyte Pharmaceuticals, Inc. ATP synthase subunits
US6673538B1 (en) 1997-07-25 2004-01-06 The Trustees Of Boston University Methods and compositions for designing vaccines
US6790950B2 (en) 1999-04-09 2004-09-14 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
CA2366520C (en) * 1999-04-09 2013-10-01 Zoetis Services Llc Anti-bacterial vaccine compositions
WO2000078922A2 (en) 1999-06-21 2000-12-28 North Carolina State University Acid-inducible promoters for gene expression
AU4204800A (en) 1999-07-12 2001-01-30 Xoma Technology Ltd. Method to identify inhibitors f1/f0 atpase

Also Published As

Publication number Publication date
US20090202594A1 (en) 2009-08-13
JP4892134B2 (ja) 2012-03-07
AU2005203189A1 (en) 2005-08-18
EP2281835B1 (en) 2013-11-06
KR20060116041A (ko) 2006-11-13
JP2002541790A (ja) 2002-12-10
KR20070011622A (ko) 2007-01-24
AR029622A1 (es) 2003-07-10
CN1351653A (zh) 2002-05-29
EP2281835A2 (en) 2011-02-09
JP2016019528A (ja) 2016-02-04
US20150182615A1 (en) 2015-07-02
EP1860117A2 (en) 2007-11-28
EP1860117A3 (en) 2008-09-03
US7763262B2 (en) 2010-07-27
AU4077600A (en) 2000-11-14
JP5973634B2 (ja) 2016-08-23
WO2000061724A2 (en) 2000-10-19
EP2281835A3 (en) 2011-11-23
KR20060134225A (ko) 2006-12-27
JP2010284165A (ja) 2010-12-24
WO2000061724A3 (en) 2001-02-01
AU2005203189B2 (en) 2007-12-20
US20120148625A1 (en) 2012-06-14
US9289486B2 (en) 2016-03-22
MXPA01010207A (es) 2003-07-21
KR20010112937A (ko) 2001-12-22
US20100322975A1 (en) 2010-12-23
EP2281834A3 (en) 2011-11-23
EP2281834A2 (en) 2011-02-09
EP2281833A2 (en) 2011-02-09
CA2366520C (en) 2013-10-01
HK1045856A1 (zh) 2002-12-13
US20070237793A1 (en) 2007-10-11
JP2013121347A (ja) 2013-06-20
JP5377433B2 (ja) 2013-12-25
EP2281833A3 (en) 2011-11-30
EP2281833B1 (en) 2014-07-02
EP1171577A2 (en) 2002-01-16
US8974798B2 (en) 2015-03-10
NZ530012A (en) 2005-10-28
ES2439645T3 (es) 2014-01-24
ES2535961T3 (es) 2015-05-19
AU780887B2 (en) 2005-04-21
EP2281834B1 (en) 2015-03-04
NZ514883A (en) 2004-03-26
CA2366520A1 (en) 2000-10-19

Similar Documents

Publication Publication Date Title
BR0009663A (pt) Composições de vacinas antibacterianas
GEP19991538B (en) Derivatives of Erytromycin and Pharmaceutical Composition on their Basis
NO964966L (no) Lactobacillusstammer av human opprinnelse, blandinger samt anvendelse derav
BR0009166A (pt) Vacina
KR0145958B1 (en) Antibacterial agents
DK0688789T3 (da) Lipopeptidderivater, fremgangsmåde til deres fremstilling samt deres anvendelse
BR0113822A (pt) Vacina
DE69839699D1 (de) Vaginales lactobacillus-medikament
FR11C0037I2 (fr) Antibiotiques macrolides et traitement de la pasteurellose
BR0010418B1 (pt) microorganismo de salmonella, composiÇço de vacina e uso do referido microorganismo.
ATE219511T1 (de) Streptococcus equi impstoff
PT1042340E (pt) Oxima de 6-o-alquil-eritromicina b
WO2002075507A3 (en) Anti-bacterial vaccine compositions
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
DE60133198D1 (en) Glykopeptidderivate mit carboxysacchariden
WO1999001473A3 (en) Anti-bacterial methods and materials
PT866791E (pt) Diaminopirimidinas formulacoes farmaceuticas que as contem e sua utilizacao antibacteriana
WO2000058475A3 (en) Streptococcus pneumoniae antigens
AP1502A (en) Genes and proteins, and their uses.
DK0858501T3 (da) Mælkesyrebakteriepræparater samt deres anvendelse til fremstilling af kolesterolsænkende produkter
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
PT1358159E (pt) Tartrato e fosfato de 3,4 diaminopiridina, as suas composições farmacêuticas e as suas utilizações
NZ513603A (en) ADP-ribosylation inhibitors and remedies for endotoxic bacterial enteric infection containing proanthocyanidin as the active ingredient

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009.